RSV

Higher RSV Hospitalization Risk in Preemies After 2014 Guidance

By October 18, 2017

A decline in immunoprophylaxis was associated with an increased risk of RSV hospitalization among infants 29-34 weeks gestational age who were <6 months of age for both commercial- and Medicaid-insured.

Regeneron to Discontinue Development of RSV Treatment

By August 14, 2017

The primary endpoint of RSV prevention - assessed through day 150 of treatment - was not significantly reached.